Michael Ussher1, Geetanjali Kakar2, Peter Hajek3, Robert West4. 1. Population Health Research Institute, St. George's University of London, Cranmer Terrace, London SW17 ORE, UK. Electronic address: mussher@sgul.ac.uk. 2. Population Health Research Institute, St. George's University of London, Cranmer Terrace, London SW17 ORE, UK. 3. Academic Tobacco Dependence Research Unit, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, 55 Philpot Street, Whitechapel, London E1 2HJ, UK. 4. Cancer Research UK Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London WC1 6BT, UK.
Abstract
INTRODUCTION: It is not known how well motivation to stop smoking predicts abstinence in a clinical sample relative to the most widely used measure of cigarette dependence. METHODS: A secondary analysis was conducted from a trial with 864 smokers making quit attempt. Fagerström Test of Cigarette Dependence (FTCD), Heaviness of Smoking Index (HSI), and motivation to stop smoking (composite of determination to quit and importance of quitting) were measured at baseline. Continuous smoking abstinence, validated by expired-air carbon monoxide, was assessed at 4weeks, 6months and 12months post-quit date. FTCD, HSI, non-HSI items in FTCD, and motivation were assessed as predictors of abstinence. RESULTS: In multiple-logistic regressions, controlling for age, gender and medication use, lower scores for FTCD, HSI and non-HSI all significantly predicted abstinence at all follow-ups, while motivation did not predict abstinence at any time. Likelihood ratio tests showed that the FTCD contributed most to the model at 4weeks and 6months; at 12months FTCD and non-HSI equally contributed most to the model. At 4weeks and 6months, predictions were improved by combining HSI and non-HSI components, compared with using these components alone. CONCLUSIONS: Cigarette dependence, measured by the FTCD, or by its HSI or non-HSI components, predicts both short-term and medium-term outcomes of attempts to stop smoking in treatment-seeking smokers involved in a clinical trial, whereas strength of motivation to stop predicts neither. Both the HSI and non-HSI components may be considered as briefer alternatives to the full FTCD.
INTRODUCTION: It is not known how well motivation to stop smoking predicts abstinence in a clinical sample relative to the most widely used measure of cigarette dependence. METHODS: A secondary analysis was conducted from a trial with 864 smokers making quit attempt. Fagerström Test of Cigarette Dependence (FTCD), Heaviness of Smoking Index (HSI), and motivation to stop smoking (composite of determination to quit and importance of quitting) were measured at baseline. Continuous smoking abstinence, validated by expired-air carbon monoxide, was assessed at 4weeks, 6months and 12months post-quit date. FTCD, HSI, non-HSI items in FTCD, and motivation were assessed as predictors of abstinence. RESULTS: In multiple-logistic regressions, controlling for age, gender and medication use, lower scores for FTCD, HSI and non-HSI all significantly predicted abstinence at all follow-ups, while motivation did not predict abstinence at any time. Likelihood ratio tests showed that the FTCD contributed most to the model at 4weeks and 6months; at 12months FTCD and non-HSI equally contributed most to the model. At 4weeks and 6months, predictions were improved by combining HSI and non-HSI components, compared with using these components alone. CONCLUSIONS: Cigarette dependence, measured by the FTCD, or by its HSI or non-HSI components, predicts both short-term and medium-term outcomes of attempts to stop smoking in treatment-seeking smokers involved in a clinical trial, whereas strength of motivation to stop predicts neither. Both the HSI and non-HSI components may be considered as briefer alternatives to the full FTCD.
Authors: Michael Le Grande; Ron Borland; Hua-Hie Yong; K Michael Cummings; Ann McNeill; Mary E Thompson; Geoffrey T Fong Journal: Nicotine Tob Res Date: 2021-01-22 Impact factor: 4.244
Authors: Su Fen Lubitz; Alex Flitter; E Paul Wileyto; Douglas Ziedonis; Nathaniel Stevens; Frank Leone; David Mandell; John Kimberly; Rinad Beidas; Robert A Schnoll Journal: Nicotine Tob Res Date: 2020-08-24 Impact factor: 4.244
Authors: Christopher Deutsch; Beth C Bock; Ryan Lantini; Kristen Walaska; Rochelle K Rosen; Joseph L Fava; Ernestine G Jennings; Robert Foster; William Flanagan Journal: Contemp Clin Trials Date: 2019-04-15 Impact factor: 2.226
Authors: Elias M Klemperer; Robin Mermelstein; Timothy B Baker; John R Hughes; Michael C Fiore; Megan E Piper; Tanya R Schlam; Douglas E Jorenby; Linda M Collins; Jessica W Cook Journal: Nicotine Tob Res Date: 2020-08-24 Impact factor: 4.244
Authors: Dana Rubenstein; Alexander W Sokolovsky; Elizabeth R Aston; Nicole L Nollen; Christopher H Schmid; Myra Rice; Kim Pulvers; Jasjit S Ahluwalia Journal: Addict Behav Date: 2021-07-01 Impact factor: 3.913
Authors: Emara Nabi-Burza; Jeremy E Drehmer; Bethany Hipple Walters; M C Willemsen; Maurice P A Zeegers; Jonathan P Winickoff Journal: J Smok Cessat Date: 2021-03-17